FALLAHI, POUPAK
 Distribuzione geografica
Continente #
NA - Nord America 16.598
EU - Europa 5.998
AS - Asia 2.343
AF - Africa 161
SA - Sud America 31
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 25.147
Nazione #
US - Stati Uniti d'America 16.267
IT - Italia 2.804
SE - Svezia 1.187
CN - Cina 1.096
BG - Bulgaria 707
SG - Singapore 416
VN - Vietnam 404
CA - Canada 327
DE - Germania 326
GB - Regno Unito 206
FI - Finlandia 198
TR - Turchia 197
UA - Ucraina 153
RU - Federazione Russa 147
CI - Costa d'Avorio 81
IN - India 79
HK - Hong Kong 78
CH - Svizzera 44
FR - Francia 41
BE - Belgio 37
SN - Senegal 34
IQ - Iraq 30
NL - Olanda 29
NG - Nigeria 28
PL - Polonia 23
AT - Austria 19
IE - Irlanda 16
BR - Brasile 14
CZ - Repubblica Ceca 13
ES - Italia 12
RO - Romania 11
IR - Iran 10
AU - Australia 8
BJ - Benin 8
EU - Europa 6
GR - Grecia 6
JP - Giappone 6
PT - Portogallo 6
EG - Egitto 5
CO - Colombia 4
EC - Ecuador 4
HU - Ungheria 4
IL - Israele 4
KR - Corea 4
MX - Messico 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
CL - Cile 3
RS - Serbia 3
DK - Danimarca 2
DZ - Algeria 2
KZ - Kazakistan 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MU - Mauritius 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 25.147
Città #
Fairfield 2.488
Woodbridge 2.049
Houston 1.379
Chandler 1.180
Ann Arbor 1.165
Ashburn 1.118
Seattle 1.067
Serra 985
Wilmington 863
Cambridge 861
Sofia 707
Milan 595
Beijing 442
New York 431
Boardman 355
Princeton 343
Ottawa 307
Lawrence 286
Medford 264
Pisa 257
Nanjing 193
Jacksonville 184
Izmir 180
Des Moines 179
Singapore 178
Dong Ket 174
San Diego 124
Florence 110
Dearborn 87
Abidjan 81
Hong Kong 73
Rome 73
Boulder 65
Nanchang 62
Ogden 55
Frankfurt am Main 52
Kunming 50
London 49
Redwood City 47
Bremen 45
Falls Church 42
Hebei 41
Norwalk 40
Changsha 39
Shenyang 39
Brussels 36
Bern 34
Dakar 34
Jüchen 31
Los Angeles 31
Dallas 29
Washington 27
Jiaxing 25
Lagos 25
Rho 25
Hefei 24
Pune 24
Tianjin 23
Chicago 22
Phoenix 21
Hyderabad 20
Sulaymaniyah 20
Indiana 19
Livorno 19
Vienna 18
Guangzhou 17
Warsaw 17
Zhengzhou 17
Dublin 16
Massa 16
San Francisco 16
Amsterdam 15
Carrara 14
Lancaster 13
Parma 13
Detroit 12
Kent 11
Chengdu 10
Jinan 10
Auburn Hills 9
Changchun 9
Lanzhou 9
Shanghai 9
Sundbyberg 9
Cotonou 8
Kilburn 8
Edinburgh 7
Hangzhou 7
Ningbo 7
Renton 7
São Paulo 7
Bergamo 6
Fremont 6
Grafing 6
Minneapolis 6
Nürnberg 6
Toronto 6
Wuhan 6
Camaiore 5
Cascina 5
Totale 20.256
Nome #
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 187
A new class of tyrosine kinase inhibitors, “pyrazolo[3,4-d]pyrimidinic”compounds, has antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer 186
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 161
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 158
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 156
B-cells and mixed cryoglobulinemia. 155
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 155
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 150
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 148
HCV-related autoimmune and neoplastic disorders: the HCV syndrome 143
3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats 142
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 142
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. 141
Increased CXCL9 Serum Levels in Hepatitis C-Related Mixed Cryoglobulinemia, with Autoimmune Thyroiditis, Associated with High Levels of CXCL10 140
Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts. 137
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 137
Sorafenib and Thyroid Cancer 132
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 132
Sunitinib in the treatment of thyroid cancer 130
Cytokines and HCV-Related Disorders. 129
Aggressive thyroid cancer: targeted therapy with sorafenib 129
CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes 126
Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. 125
Cytokines and HCV-related autoimmune disorders 124
Cabozantinib in Thyroid Cancer 124
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. 123
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 123
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 123
The Endocrinology of Liver Disease. 122
RET TKI: Potential Role in Thyroid Cancers 122
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 122
Thyroid involvement in hepatitis C - Associated mixed cryoglobulinemia 121
An iron regulatory gene signature in breast cancer: More than a prognostic genetic profile? 119
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 119
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 119
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 119
Sorafenib in the treatment of thyroid cancer 119
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 119
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 118
New targeted molecular therapies for dedifferentiated thyroid cancer. 116
Analysis of chromosome damage in circulating lymphocytes of radiological workers affected by thyroid nodules 116
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 115
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 114
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 114
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up 113
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 112
New targeted therapies for anaplastic thyroid cancer. 112
Antibodies recognizing specific Mycobacterium avium subsp. paratuberculosis's MAP3738c protein in type 1 diabetes mellitus children are associated with serum Th1 (CXCL10) chemokine. 112
Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident 112
TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation 111
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 111
The emerging extrahepatic manifestations oh hepatitis C virus infection in chronic hepatitis and mixed cryoglobulinemia. 110
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 110
Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature 110
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. 109
The Role of Total Thyroidectomy in the Initial Treatment of Well-differentiated Follicular-cell-derived Thyroid Carcinomas 109
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 108
Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer 107
Thyroid cancer in HCV-related mixed cryoglobulinemia patients. 106
Hepatitis C virus infection - Evidence for an association with type 2 diabetes 106
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 106
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 106
CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation 105
Tyrosine Kinase Inhibitors; Therapies for Thyroid Cancer 105
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. 105
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis 104
null 104
Autoimmune thyroid disorders 104
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 104
null 103
null 103
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study 103
Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis. 102
Dedifferentiated thyroid cancer: a therapeutic challenge 102
Novel treatment options for anaplastic thyroid cancer 102
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 102
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 102
Body composition and cardiac dimensions in elite rhythmic gymnasts 101
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 101
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 100
Changes in autonomic regulation and ventricular repolarization induced by subclinical hyperthyroidism 100
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis. 100
null 100
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 100
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition 100
Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes 99
Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. 99
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. 99
Selective use of vandetanib in the treatment of thyroid cancer 99
Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer 99
Deregulated expression of VHL mRNA variants in papillary thyroid cancer 99
L’esperienza della Medicina del Lavoro della Azienda Ospedaliero-Universitaria Pisana nella sorveglianza sanitaria degli ex-esposti ad amianto, alla luce delle linee di indirizzo della regione Toscana 99
Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease 98
Prevalence of hypothyroidism and Graves disease in sarcoidosis 97
Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis. 97
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration. 97
Current and future immunotherapies for thyroid cancer 97
null 97
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 97
The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer 96
Totale 11.643
Categoria #
all - tutte 75.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.686 0 0 935 355 520 548 699 620 1.021 430 405 153
2020/20212.728 267 224 298 98 182 98 83 361 172 322 143 480
2021/20223.378 70 154 119 214 554 460 97 223 171 145 228 943
2022/20233.428 502 409 225 306 373 504 58 249 498 15 242 47
2023/20242.911 290 325 360 230 429 521 144 108 47 54 101 302
2024/2025695 219 375 101 0 0 0 0 0 0 0 0 0
Totale 26.222